Recurrent Extrahepatic Bile Duct Carcinoma
2 clinical trials · Condition
◉ Watch Recurrent Extrahepatic Bile Duct Carcinoma
| Record | Firm | Date |
|---|---|---|
| Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery (NCT02042443) | National Cancer Institute (NCI) | 2014-02-01 |
| Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma (NCT01093222) | National Cancer Institute (NCI) | 2010-04-01 |
Track Recurrent Extrahepatic Bile Duct Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.